These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 31167790

  • 1. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
    Ueda M, Okada M, Mizuguchi M, Kluve-Beckerman B, Kanenawa K, Isoguchi A, Misumi Y, Tasaki M, Ueda A, Kanai A, Sasaki R, Masuda T, Inoue Y, Nomura T, Shinriki S, Shuto T, Kai H, Yamashita T, Matsui H, Benson MD, Ando Y.
    J Biol Chem; 2019 Jul 19; 294(29):11259-11275. PubMed ID: 31167790
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.
    Schmidt M, Wiese S, Adak V, Engler J, Agarwal S, Fritz G, Westermark P, Zacharias M, Fändrich M.
    Nat Commun; 2019 Nov 01; 10(1):5008. PubMed ID: 31676763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasminogen activation triggers transthyretin amyloidogenesis in vitro.
    Mangione PP, Verona G, Corazza A, Marcoux J, Canetti D, Giorgetti S, Raimondi S, Stoppini M, Esposito M, Relini A, Canale C, Valli M, Marchese L, Faravelli G, Obici L, Hawkins PN, Taylor GW, Gillmore JD, Pepys MB, Bellotti V.
    J Biol Chem; 2018 Sep 14; 293(37):14192-14199. PubMed ID: 30018138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transthyretin: Its function and amyloid formation.
    Ueda M.
    Neurochem Int; 2022 May 14; 155():105313. PubMed ID: 35218869
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
    Lashuel HA, Lai Z, Kelly JW.
    Biochemistry; 1998 Dec 22; 37(51):17851-64. PubMed ID: 9922152
    [Abstract] [Full Text] [Related]

  • 12. Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.
    Higaki JN, Chakrabartty A, Galant NJ, Hadley KC, Hammerson B, Nijjar T, Torres R, Tapia JR, Salmans J, Barbour R, Tam SJ, Flanagan K, Zago W, Kinney GG.
    Amyloid; 2016 Jun 22; 23(2):86-97. PubMed ID: 26981744
    [Abstract] [Full Text] [Related]

  • 13. A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis).
    Gonzalez-Duarte A, Ulloa-Aguirre A.
    Int J Mol Sci; 2021 Dec 06; 22(23):. PubMed ID: 34884963
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y, Otagiri M.
    Life Sci; 2013 Dec 18; 93(25-26):1017-22. PubMed ID: 24211615
    [Abstract] [Full Text] [Related]

  • 20. One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.
    Suhr OB, Lundgren E, Westermark P.
    J Intern Med; 2017 Apr 18; 281(4):337-347. PubMed ID: 28093848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.